Skip to content

Exploring the mechanism and efficacy evaluation of modified Cangfu Daotan Tang on endometrial receptivity in patients with recurrent abortion and insulin resistance based on lipid metabolism

Exploring the mechanism and efficacy evaluation of modified Cangfu Daotan Tang on endometrial receptivity in patients with recurrent abortion and insulin resistance based on lipid metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076160
Enrollment
Unknown
Registered
2023-09-26
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent spontaneous abortion

Interventions

control group:dietary and exercise
Western Medicine Group:dietary,exercise and metformin
Integrated Traditional Chinese and Western Medicine Group:dietary,exercise,metformin and cangfu daotan tang

Sponsors

Wenling Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1: recurrent spontaneous abortion 2: Insulin resistance 3: 20-40 years old 4: Individuals without previous severe underlying diseases 5: Agree to conduct relevant investigations and experimental examinations 6: Agree to use non pharmacological contraception during sexual activity during the experimental period

Exclusion criteria

Exclusion criteria: 1: Recurrent abortion caused by chromosome abnormality, uterine dysplasia, infection, cervical incompetence, immune factors, etc 2: Patients with abnormal liver and kidney function, allergic or intolerant to this drug 3: Those who have used hormone drugs in the past 3 months 4: Failure to take medication according to regulations 5: Spouse with abnormal reproductive function 6: Patients with consciousness disorders or mental illnesses 7: Refusal to conduct laboratory related examinations

Design outcomes

Primary

MeasureTime frame
blood lipids;Endometrial receptivity evaluated by transvaginal ultrasound;Pregnancy rate;

Countries

China

Contacts

Public ContactWang Qiaotong

Wenling Maternity and Child Health Care Hospital

wangqiaotong@126.com+86 157 5712 5290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026